Pfizer (PFE) with a notable insider buy on 8/6 from director Ronald Blaylock of 13,000 shares at $38.55, a more than $500,000 investment. Blaylock is the founder of Gennx360, a private equity firm, and joined the Pfizer board in 2017. PFE is consolid...